Form 8-K - Current report:
SEC Accession No. 0000950170-25-051353
Filing Date
2025-04-07
Accepted
2025-04-07 07:40:08
Documents
13
Period of Report
2025-04-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrn-20250404.htm   iXBRL 8-K 54661
2 EX-99.1 amrn-ex99_1.htm EX-99.1 12767
3 GRAPHIC img114078973_0.jpg GRAPHIC 31581
  Complete submission text file 0000950170-25-051353.txt   239900

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20250404.xsd EX-101.SCH 32939
16 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20250404_htm.xml XML 4767
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 25816373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)